A RANDOMIZED PHASE 2 TRIAL OF CEDIRANIB IN COMBINATION WITH OLAPARIB VERSUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA
Publication
, Conference
Arrillaga-Romany, I; Sahebjam, S; Picconi, D; Campian, J; Giglio, P; Drappatz, J; Aiken, R; Villano, J; Lee, E; Welch, M; Ellingson, B; Ney, D ...
Published in: NEURO-ONCOLOGY
November 1, 2019
Duke Scholars
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 1, 2019
Volume
21
Start / End Page
27 / 27
Location
Phoenix, AZ
Publisher
OXFORD UNIV PRESS INC
Conference Name
24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Arrillaga-Romany, I., Sahebjam, S., Picconi, D., Campian, J., Giglio, P., Drappatz, J., … Gerstner, E. (2019). A RANDOMIZED PHASE 2 TRIAL OF CEDIRANIB IN COMBINATION WITH OLAPARIB VERSUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA. In NEURO-ONCOLOGY (Vol. 21, pp. 27–27). Phoenix, AZ: OXFORD UNIV PRESS INC.
Arrillaga-Romany, Isabel, Solmaz Sahebjam, David Picconi, Jian Campian, Pierre Giglio, Jan Drappatz, Robert Aiken, et al. “A RANDOMIZED PHASE 2 TRIAL OF CEDIRANIB IN COMBINATION WITH OLAPARIB VERSUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA.” In NEURO-ONCOLOGY, 21:27–27. OXFORD UNIV PRESS INC, 2019.
Arrillaga-Romany I, Sahebjam S, Picconi D, Campian J, Giglio P, Drappatz J, et al. A RANDOMIZED PHASE 2 TRIAL OF CEDIRANIB IN COMBINATION WITH OLAPARIB VERSUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2019. p. 27–27.
Arrillaga-Romany, Isabel, et al. “A RANDOMIZED PHASE 2 TRIAL OF CEDIRANIB IN COMBINATION WITH OLAPARIB VERSUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA.” NEURO-ONCOLOGY, vol. 21, OXFORD UNIV PRESS INC, 2019, pp. 27–27.
Arrillaga-Romany I, Sahebjam S, Picconi D, Campian J, Giglio P, Drappatz J, Aiken R, Villano J, Lee E, Welch M, Ellingson B, Ney D, Becker K, Muzikansky A, Das B, Swisher E, Nixon A, Karlovich C, Williams PM, Ivy SP, Batchelor T, Gerstner E. A RANDOMIZED PHASE 2 TRIAL OF CEDIRANIB IN COMBINATION WITH OLAPARIB VERSUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2019. p. 27–27.
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 1, 2019
Volume
21
Start / End Page
27 / 27
Location
Phoenix, AZ
Publisher
OXFORD UNIV PRESS INC
Conference Name
24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences